EZR and esophageal squamous cell carcinoma: To clarify the ability of autoantibodies against Ezrin in serum in ESCC diagnosis, we conducted enzyme-linked immunosorbent assay (ELISA) to investigate levels of autoantibodies against Ezrin in 149 ESCC patients and 98 normal controls and did western blot to confirm the results.